Ebselen Exerts Antifungal Activity by Regulating Glutathione (GSH) and Reactive Oxygen Species (ROS) Production in Fungal Cells

Overview

Journal Biochim Biophys Acta Gen Subj

Publisher Elsevier

Specialties Biochemistry
Biophysics

Date 2016 Nov 6

PMID 27712973

Citations 52

Authors

Shankar Thangamani

Hassan E Eldesouky

Haroon Mohammad

Pete E Pascuzzi

Larisa Avramova

Tony R Hazbun

Mohamed N Seleem

Affiliations

Soon will be listed here.

Abstract

Background: Ebselen, an organoselenium compound and a clinically safe molecule has been reported to possess potent antifungal activity, but its antifungal mechanism of action and in vivo antifungal activity remain unclear.

Methods: The antifungal effect of ebselen was tested against Candida albicans, C. glabrata, C. tropicalis, C. parapsilosis, Cryptococcus neoformans, and C. gattii clinical isolates. Chemogenomic profiling and biochemical assays were employed to identify the antifungal target of ebselen. Ebselen's antifungal activity in vivo was investigated in a Caenorhabditis elegans animal model.

Results: Ebselen exhibits potent antifungal activity against both Candida spp. and Cryptococcus spp., at concentrations ranging from 0.5 to 2μg/ml. Ebselen rapidly eradicates a high fungal inoculum within 2h of treatment. Investigation of the drug's antifungal mechanism of action indicates that ebselen depletes intracellular glutathione (GSH) levels, leading to increased production of reactive oxygen species (ROS), and thereby disturbs the redox homeostasis in fungal cells. Examination of ebselen's in vivo antifungal activity in two Caenorhabditis elegans models of infection demonstrate that ebselen is superior to conventional antifungal drugs (fluconazole, flucytosine and amphotericin) in reducing Candida and Cryptococcus fungal load.

Conclusion: Ebselen possesses potent antifungal activity against clinically relevant isolates of both Candida and Cryptococcus by regulating GSH and ROS production. The potent in vivo antifungal activity of ebselen supports further investigation for repurposing it for use as an antifungal agent.

General Significance: The present study shows that ebselen targets glutathione and also support that glutathione as a potential target for antifungal drug development.

Citing Articles

Glutathione: A Key Regulator of Extracellular Matrix and Cell Death in Intervertebral Disc Degeneration.

Li F, Li S, Shi Y, Lin F, Rui L, Shi J Mediators Inflamm. 2024; 2024:4482642.

PMID: 39403548 PMC: 11473174. DOI: 10.1155/2024/4482642.

Overcoming amphotericin B resistance in using the antiemetic drug rolapitant.

Salama E, Elgammal Y, Utturkar S, Lanman N, Hazbun T, Seleem M Antimicrob Agents Chemother. 2024; 68(11):e0055624.

PMID: 39387581 PMC: 11539225. DOI: 10.1128/aac.00556-24.

Analysis of the anti-Candida activity of tricyclic antidepressants in association with amphotericin B and their antifungal mechanisms.

de Farias Cabral V, Rodrigues D, Sa L, Moreira L, da Silva C, de Andrade Neto J Braz J Microbiol. 2024; 55(4):3617-3628.

PMID: 39198376 PMC: 11711746. DOI: 10.1007/s42770-024-01459-y.

Novel combinatorial approach: Harnessing HIV protease inhibitors to enhance amphotericin B's antifungal efficacy in cryptococcosis.

Alkashef N, Seleem M PLoS One. 2024; 19(8):e0308216.

PMID: 39088434 PMC: 11293717. DOI: 10.1371/journal.pone.0308216.

Following the Trace of Cyclodextrins on the Selenium and Tellurium Odyssey.

Moran-Serradilla C, Plano D, Sharma A, Sanmartin C Int J Mol Sci. 2024; 25(14).

PMID: 39063040 PMC: 11277100. DOI: 10.3390/ijms25147799.

References

Jarvis J, Harrison T . HIV-associated cryptococcal meningitis. AIDS. 2007; 21(16):2119-29. DOI: 10.1097/QAD.0b013e3282a4a64d. View

Yadav A, Desai P, Rai M, Kaur R, Ganesan K, Bachhawat A . Glutathione biosynthesis in the yeast pathogens Candida glabrata and Candida albicans: essential in C. glabrata, and essential for virulence in C. albicans. Microbiology (Reading). 2010; 157(Pt 2):484-495. DOI: 10.1099/mic.0.045054-0. View

Zembowicz A, Hatchett R, Radziszewski W, Gryglewski R . Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase. J Pharmacol Exp Ther. 1993; 267(3):1112-8. View

Schewe T . Molecular actions of ebselen--an antiinflammatory antioxidant. Gen Pharmacol. 1995; 26(6):1153-69. DOI: 10.1016/0306-3623(95)00003-j. View

Robinson M, McCarthy D, Smyth G . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009; 26(1):139-40. PMC: 2796818. DOI: 10.1093/bioinformatics/btp616. View

Roemer T, Davies J, Giaever G, Nislow C . Bugs, drugs and chemical genomics. Nat Chem Biol. 2011; 8(1):46-56. DOI: 10.1038/nchembio.744. View

Odds F, Brown A, Gow N . Antifungal agents: mechanisms of action. Trends Microbiol. 2003; 11(6):272-9. DOI: 10.1016/s0966-842x(03)00117-3. View

Ngo H, Shrestha S, Garneau-Tsodikova S . Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity. ChemMedChem. 2016; 11(14):1507-16. PMC: 5060091. DOI: 10.1002/cmdc.201600236. View

Lewis R . Current concepts in antifungal pharmacology. Mayo Clin Proc. 2011; 86(8):805-17. PMC: 3146381. DOI: 10.4065/mcp.2011.0247. View

10.

Chan G, Hardej D, Santoro M, Lau-Cam C, Billack B . Evaluation of the antimicrobial activity of ebselen: role of the yeast plasma membrane H+-ATPase. J Biochem Mol Toxicol. 2007; 21(5):252-64. DOI: 10.1002/jbt.20189. View

11.

Thangamani S, Younis W, Seleem M . Repurposing celecoxib as a topical antimicrobial agent. Front Microbiol. 2015; 6:750. PMC: 4517059. DOI: 10.3389/fmicb.2015.00750. View

12.

Abushahba M, Mohammad H, Thangamani S, Hussein A, Seleem M . Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens. Sci Rep. 2016; 6:20832. PMC: 4748415. DOI: 10.1038/srep20832. View

13.

Giaever G, Flaherty P, Kumm J, Proctor M, Nislow C, Jaramillo D . Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Natl Acad Sci U S A. 2004; 101(3):793-8. PMC: 321760. DOI: 10.1073/pnas.0307490100. View

14.

Thangamani S, Younis W, Seleem M . Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens. PLoS One. 2015; 10(7):e0133877. PMC: 4519285. DOI: 10.1371/journal.pone.0133877. View

15.

Grant C, Dawes I . Synthesis and role of glutathione in protection against oxidative stress in yeast. Redox Rep. 2016; 2(4):223-9. DOI: 10.1080/13510002.1996.11747054. View

16.

Desai P, Thakur A, Ganguli D, Paul S, Morschhauser J, Bachhawat A . Glutathione utilization by Candida albicans requires a functional glutathione degradation (DUG) pathway and OPT7, an unusual member of the oligopeptide transporter family. J Biol Chem. 2011; 286(48):41183-41194. PMC: 3308832. DOI: 10.1074/jbc.M111.272377. View

17.

Thangamani S, Mohammad H, Abushahba M, Sobreira T, Hedrick V, Paul L . Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens. Sci Rep. 2016; 6:22571. PMC: 4776257. DOI: 10.1038/srep22571. View

18.

Azad G, Singh V, Mandal P, Singh P, Golla U, Baranwal S . Ebselen induces reactive oxygen species (ROS)-mediated cytotoxicity in Saccharomyces cerevisiae with inhibition of glutamate dehydrogenase being a target. FEBS Open Bio. 2014; 4:77-89. PMC: 3907691. DOI: 10.1016/j.fob.2014.01.002. View

19.

Park B, Wannemuehler K, Marston B, Govender N, Pappas P, Chiller T . Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009; 23(4):525-30. DOI: 10.1097/QAD.0b013e328322ffac. View

20.

Nozawa R, Yokota T, Fujimoto T . Susceptibility of methicillin-resistant Staphylococcus aureus to the selenium-containing compound 2-phenyl-1,2-benzoisoselenazol-3(2H)-one (PZ51). Antimicrob Agents Chemother. 1989; 33(8):1388-90. PMC: 172662. DOI: 10.1128/AAC.33.8.1388. View